These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 36854506)

  • 1. Isophysalin A Inhibits the Stemness of Breast Cancer Cells Possibly
    Ko YC; Choi HS; Kim SL; Lee DS
    Anticancer Res; 2023 Mar; 43(3):1091-1101. PubMed ID: 36854506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells.
    Kim SL; Choi HS; Lee DS
    Cell Commun Signal; 2023 Nov; 21(1):315. PubMed ID: 37924094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Desmethylsinensetin isolated from Artemisia princeps suppresses the stemness of breast cancer cells via Stat3/IL-6 and Stat3/YAP1 signaling.
    Liu R; Choi HS; Ko YC; Yun BS; Lee DS
    Life Sci; 2021 Sep; 280():119729. PubMed ID: 34146553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6/STAT3/NF-kB signaling pathways.
    Lin C; Wang L; Wang H; Yang L; Guo H; Wang X
    J Cell Biochem; 2013 Sep; 114(9):2061-70. PubMed ID: 23553622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 13-Oxo-9Z,11E-octadecadienoic Acid Down-regulates c-Myc and Attenuates Breast Cancer Cell Stemness.
    Ko YC; Choi HS; Kim SL; Lee DS
    In Vivo; 2023; 37(3):1085-1092. PubMed ID: 37103085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esculentoside A suppresses breast cancer stem cell growth through stemness attenuation and apoptosis induction by blocking IL-6/STAT3 signaling pathway.
    Liu C; Dong L; Sun Z; Wang L; Wang Q; Li H; Zhang J; Wang X
    Phytother Res; 2018 Nov; 32(11):2299-2311. PubMed ID: 30080291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betavulgarin Isolated from Sugar Beet (
    Liu R; Choi HS; Zhen X; Kim SL; Kim JH; Ko YC; Yun BS; Lee DS
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32630026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catechol derived from aronia juice through lactic acid bacteria fermentation inhibits breast cancer stem cell formation via modulation Stat3/IL-6 signaling pathway.
    Choi HS; Kim JH; Kim SL; Deng HY; Lee D; Kim CS; Yun BS; Lee DS
    Mol Carcinog; 2018 Nov; 57(11):1467-1479. PubMed ID: 29964299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
    Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
    Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory Effects of Tangeretin, A Citrus Peel-Derived Flavonoid, on Breast Cancer Stem Cell Formation through Suppression of Stat3 Signaling.
    Ko YC; Choi HS; Liu R; Kim JH; Kim SL; Yun BS; Lee DS
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32503228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway.
    Kim SL; Choi HS; Kim JH; Jeong DK; Kim KS; Lee DS
    Oxid Med Cell Longev; 2019; 2019():9296439. PubMed ID: 31019654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of STAT3 signaling in ALDH+ and ALDH+/CD44+/CD24- subpopulations of breast cancer cells.
    Lin L; Hutzen B; Lee HF; Peng Z; Wang W; Zhao C; Lin HJ; Sun D; Li PK; Li C; Korkaya H; Wicha MS; Lin J
    PLoS One; 2013; 8(12):e82821. PubMed ID: 24376586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
    Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
    Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Breast Cancer Activities of Ketoprofen-RGD Conjugate by Targeting Breast Cancer Stem-Like Cells and Parental Cells.
    Noori S; Rajabi S; Tavirani MR; Shokri B; Zarghi A
    Anticancer Agents Med Chem; 2021; 21(8):1027-1036. PubMed ID: 32900351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoharringtonine inhibits breast cancer stem-like properties and STAT3 signaling.
    Chen W; Wang H; Cheng M; Ni L; Zou L; Yang Q; Cai X; Jiao B
    Biomed Pharmacother; 2018 Jul; 103():435-442. PubMed ID: 29679903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression and significance of insulin-like growth factor-1 receptor and its pathway on breast cancer stem/progenitors.
    Chang WW; Lin RJ; Yu J; Chang WY; Fu CH; Lai A; Yu JC; Yu AL
    Breast Cancer Res; 2013 May; 15(3):R39. PubMed ID: 23663564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
    Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
    Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 as a promising chemoresistance biomarker associated with the CD44
    Moreira MP; da Conceição Braga L; Cassali GD; Silva LM
    Exp Cell Res; 2018 Feb; 363(2):283-290. PubMed ID: 29352988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy.
    Rahmati M; Johari B; Kadivar M; Rismani E; Mortazavi Y
    J Cell Physiol; 2020 Jun; 235(6):5429-5444. PubMed ID: 31912904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oct4 suppresses IR‑induced premature senescence in breast cancer cells through STAT3- and NF‑κB-mediated IL‑24 production.
    Kim JY; Kim JC; Lee JY; Park MJ
    Int J Oncol; 2018 Jul; 53(1):47-58. PubMed ID: 29749438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.